Journal of Shanghai University >
Interpretation of 2017 American Guideline for Hypertension in Adults
Received date: 2018-01-06
Online published: 2018-06-27
On November 14, 2017, American College of Cardiology (ACC) and American Heart Association (AHA), together with 9 other authorities, released 2017 American Guideline for Hypertension in Adults (2017ACC/AHA). The guideline no longer used the past diagnostic standard of hypertension, and it set up a new antihypertensive target. Ever since the issue of the guideline, experts and researchers around the world have been debating over the pros and cons of the new changes the guideline contains, and it can be expected that this guideline will continue to remain a controversial topic. This paper is an attempt to interpret the American guideline by taking into account the present situation in China.
Key words： hypertension; guideline; interpretation
PAN Xin, XU Yawei, XU Dachun . Interpretation of 2017 American Guideline for Hypertension in Adults[J]. Journal of Shanghai University, 2018 , 24(3) : 331 -335 . DOI: 10.12066/j.issn.1007-2861.2003
| [1] | W helton P K, C arey R M, A ronow W S, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/ APHA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines[J]. Hypertension, 2018,71(6):1269-1324. |
| [2] | L ewington S, C larke R, Q izilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies[J]. Lancet, 2002,361:1903-1913. |
| [3] | R apsomaniki E, T immis A, G eorge J, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people[J]. Lancet, 2014,383:1899-1911. |
| [4] | W illiamson J D, S upiano M A, A pplegate W B, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged $>$=75 years a randomized clinical trial[J]. Journal of the American Medical Association, 2016,315(24):2673-2682. |
| [5] | M untner P, C arey R M, G idding S, et al. Potential US population impact of the 2017 ACC/AHA high blood pressure guideline[J]. Journal of the American College of Cardiology, 2018,71(2):109-118. |
| [6] | B angalore S, T oklu B, G ianos E, et al. Optimal systolic blood pressure target after SPRINT: insights from a network meta-analysis of randomized trials[J]. American Journal of Medicine, 2017,130(6):707-719. |
| [7] | D enardo S J, G ong Y, N ichols W W, et al. Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy[J]. American Journal of Medicine, 2010,123(8):719-726. |
| [8] | C ushman W C, E vans G W, B yington R P, et al. Effects of intensive blood-pressure control in Type 2 diabetes mellitus[J]. New England Journal of Medicine, 2010,362(17):1575-1585. |
| [9] | Z anchetti A, H ansson L, C lement D, et al. Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers?[J]. Journal of Hypertension, 2003,21(4):797-804. |
| [10] | L onn E M, B osch J, L opez-J aramillo P, et al. Blood-pressure lowering in intermediate-risk persons without cardiovascular disease[J]. New England Journal of Medicine, 2016,374(21):2009-2020. |
| [11] | L u J P, L u Y, W ang X C, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE million persons project)[J]. Lancet, 2017,390:2549-2558. |
| [12] | W ang X B, Q in X H, D emirtas H, et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis[J]. Lancet, 2007,369:1876-1882. |
/
| 〈 |
|
〉 |
